Cannabinoids Part 3: Proceed With Caution
In our cannabinoid series that examines current dermatologic pros and cons, Dr. Shawn Kwatra is cautiously optimistic, but advises to proceed with caution.
Cannabinoids Part 2: The Legal Framework
In our cannabinoid series that examines current dermatologic pros and cons, Dr. Adam Friedman talks CBD vs medical cannabis, dispensaries, and navigating state regulations.
Cannabinoids Part 1: The Future in Dermatology
In our cannabinoid series that examines current dermatologic pros and cons, Dr. Adam Friedman discusses the potential for CBD in dermatology, the science, and current clinical trial programs.